ASHEVILLE, NC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CARSON SARCOMA FOUNDATION, founded in 2014, is a small nonprofit that reported $284K in total revenue in fiscal year 2021. The organization ran a surplus of $92K, a strong 32% operating margin.
CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS.
THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE...
THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2021 | 2020 | Change | |
|---|---|---|---|
| Revenue | $283,758 | N/A | N/A |
| Expenses | $192,184 | N/A | N/A |
| Net Income | $91,574 | N/A | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DR G THOMAS BUDD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| RANDY W CARSON | DIRECTOR | N/A |
Officer
Director
|
$0 | $0 | $0 |
| ROBERT NOYES-SMITH | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2021 | $283,758 | $192,184 | $256,564 | $91,574 |
Compare CARSON SARCOMA FOUNDATION with other nonprofits in North Carolina and across the country.